CIK 0001653087
- Accelerated filer
- Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 822933343
- Phone
- +1 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-05 | Kenkare-Mitra Sara President and Head of R&D | Sale | −6,214 | $5.19 | $32K | 177,935 |
| 2023-09-05 | Romano Gary Chief Medical Officer | Sale | −2,771 | $5.19 | $14K | 99,349 |
| 2023-09-05 | GRASSO MARC Chief Financial Officer | Sale | −1,114 | $5.19 | $6K | 32,247 |
| 2023-06-02 | Kenkare-Mitra Sara President and Head of R&D | Sale | −4,092 | $6.90 | $28K | 184,149 |
| 2023-06-02 | GRASSO MARC Chief Financial Officer | Sale | −1,050 | $6.90 | $7K | 33,361 |
| 2023-06-02 | Romano Gary Chief Medical Officer | Sale | −2,617 | $6.90 | $18K | 102,120 |
| 2023-06-02 | Rosenthal Arnon Chief Executive Officer | Sale | −5,255 | $6.90 | $36K | 1,651,095 |
| 2023-03-17 | Rosenthal Arnon Chief Executive Officer | Sale | −15,186 | $6.22 | $94K | 1,656,350 |
| 2023-03-02 | Romano Gary Chief Medical Officer | Sale | −3,238 | $8.32 | $27K | 104,737 |
| 2023-03-02 | Kenkare-Mitra Sara President and Head of R&D | Sale | −10,124 | $8.32 | $84K | 188,241 |
| 2023-03-02 | GRASSO MARC Chief Financial Officer | Sale | −1,291 | $8.32 | $11K | 34,411 |
| 2023-03-02 | Rosenthal Arnon Chief Executive Officer | Sale | −5,849 | $8.32 | $49K | 1,628,546 |
| 2022-12-02 | Romano Gary Chief Medical Officer | Sale | −2,145 | $8.71 | $19K | 107,975 |
| 2022-09-02 | Romano Gary Chief Medical Officer | Sale | −2,177 | $10.62 | $23K | 90,073 |
| 2022-09-02 | King Robert Chief Development Officer | Sale | −176 | $10.62 | $2K | 529,295 |
| 2022-06-02 | King Robert Chief Development Officer | Sale | −177 | $8.71 | $2K | 529,471 |
| 2022-03-01 | King Robert Chief Development Officer | Sale | −287 | $15.57 | $4K | 528,404 |
| 2021-12-13 | SULIMAN SHEHNAAZ President and COO | Sale | −64,102 | $21.16 | $1.4M | 113,496 |
| 2021-12-13 | SULIMAN SHEHNAAZ President and COO | Sale | −10,898 | $21.73 | $237K | 102,598 |
| 2021-12-10 | SULIMAN SHEHNAAZ President and COO | Sale | −66,126 | $21.69 | $1.4M | 111,472 |
Page 4 of 13 · 249 trades